NYSE · Medical - Devices

ABT (ABT) Stock

$109.49 -0.79% NYSE: ABT Healthcare

Valuation

MetricValue
Price$109.49
Market Cap$189.46B
P/E Ratio36.69
P/B Ratio3.89
P/S Ratio4.24
EPS (TTM)$3.72
52-Week High$137.49
52-Week Low$81.97
Dividend Yield2.21%

Financials & Margins

MetricValue
ROE10.52%
ROA4.97%
ROCE8.68%
Gross Margin56.38%
Operating Margin18.17%
Net Margin11.65%
Debt/Equity0.64
Current Ratio1.58

Annual Financials (USD)

Metric20212022202320242025
Revenue$43.1B$43.7B$40.1B$42.0B$44.3B
Operating Profit$9.2B$8.4B$6.4B$6.8B$8.0B
Net Profit$7.1B$6.9B$5.7B$13.4B$6.5B
EPS$3.94$3.91$3.27$7.64$3.72
Op Margin21.4%19.2%16.0%16.3%18.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$75.2B$74.4B$73.2B$81.4B$86.7B
Total Liabilities$39.2B$37.5B$34.4B$33.5B$33.9B
Cash$9.8B$9.9B$6.9B$7.6B$8.5B
Borrowings$19.3B$17.9B$15.9B$15.3B$15.1B

Latest News

Is Tandem Diabetes Care (TNDM) Undervalued Following Its Abbott Libre 3 Plus Expansion? Simply Wall St. · Jul 11, 2026 Abbott Labs Vs. Danaher: Abbott’s Everyday Products Beat Danaher’s Slumping Biotech Equipment 24/7 Wall St. · Jul 10, 2026 DXCM Grew. The Stock Did Not. Someone Is Wrong Trefis · Jul 10, 2026 Advanced Therapeutics (Aging and Wellness) Market Report Now Available; 146-Page Study Profiling Abbott, Nestlé, Herbalife, Amway & 11 Others, Covering Sports, Functional & Therapeutic Nutrition GlobeNewswire · Jul 10, 2026 The Wide Chasm Priced Into Boston Scientific Stock Trefis · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$10.5B$9.6B$7.3B$8.6B$9.6B
Investing Cash Flow$-3.9B$-3.5B$-5.3B$-4.5B$-4.6B
Financing Cash Flow$-2.0B$-3.6B$-1.1B$-1.0B$-975.0M
Net Cash Flow$3.0B$83.0M$-3.0B$720.0M$906.0M
Free Cash Flow$8.6B$7.8B$5.1B$6.4B$7.4B

Valuation & Return Ratios

MetricValue
PEG Ratio-0.60
EV / EBITDA22.62
FCF Yield4.42%
Quick Ratio0.97
Interest Coverage12.45
Return 1Y-12.41%
Return 3Y15.26%
Return 5Y-3.75%

Ownership

Insiders Held0.49%
Institutions Held82.45%
Institutions Float Held82.85%
Institutional HolderSharesReport Date
Blackrock Inc.145,687,4582026-03-31
Vanguard Capital Management LLC112,949,9332026-03-31
State Street Corporation79,575,4682026-03-31
Capital Research Global Investors49,775,3622026-03-31
Vanguard Portfolio Management LLC47,944,8912026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BSX $47.97 -0.69% 19.42 $71.29B 0.00%
GILD $148.94 +1.78% -56.96 $184.92B 2.21%
ISRG $369.12 -2.05% 41.86 $130.40B 0.00%
MDT $92.89 +2.47% 24.54 $118.90B 3.13%
MRK $149.59 +1.24% 121.55 $369.46B 2.22%

About ABT

ABT is led by CEO Robert Ford, employs 114,000 people, headquartered in Abbott Park, US, publicly traded since 1980.

ABT stock trades at $109.49 with a market capitalization of $189.46B. The stock is valued at a price-to-earnings (P/E) ratio of 36.69, price-to-book of 3.89, price-to-sales of 4.24. Over the past 52 weeks the stock has ranged between $81.97 and $137.49, and currently trades 20.4% below its 52-week high. It pays a dividend yielding 2.21%.

On profitability, ABT generates a return on equity (ROE) of 10.52%, return on capital employed of 8.68%, an operating margin of 18.17%, a net profit margin of 11.65%.

In its most recent fiscal year, ABT reported annual revenue of $44.3B, net profit of $6.5B, revenue has compounded at 5.1% a year over the last five years, profit at 7.7% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.64, a current ratio of 1.58, total assets of $86.7B, $8.5B in cash and equivalents.

ABT has an average daily trading volume of 11,897,095 shares, a beta of 0.58 (less volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1161.39 +0.40% JNJ Drug Manufacturers - General $270.47 +1.74% ABBV Drug Manufacturers - General $260.17 +1.46% MRK Drug Manufacturers - General $149.59 +1.24% UNH Medical - Healthcare Plans $396.10 +1.72% NVS Drug Manufacturers - General $161.48 +6.19% AZN Drug Manufacturers - General $161.96 -0.10% AMGN Drug Manufacturers - General $435.89 +1.40% TMO Medical - Diagnostics & Research $601.51 -2.53% NVO Biotechnology $45.17 -0.35% GILD Drug Manufacturers - General $148.94 +1.78% PFE Drug Manufacturers - General $28.49 +0.09%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides